For those unable to join us in Seattle, we're excited to announce our new virtual meeting option, where we'll bring the meeting to you wherever you are - on your computer or select mobile devices.

Be a part of the interactive conversation through our live streaming sessions and access over 20 hours of on-demand content. You'll have access to:

  • Live streaming access to three plenary sessions
  • On-demand recording access to the entire meeting
  • Earn up to 5 CLE and CLP hours for attending the live broadcasts!

Live Streaming of our Special Keynote & Featured Sessions

 

WEDNESDAY, MAY 15
12:30 – 1:30 EST

Solving the World's Imminent Problems with Innovative Science
The Bill & Melinda Gates Foundation, the Allen Institute for Brain Science, and the Infectious Disease Research Institute are all Seattle-based non-profit organizations that fund, manage and engage in life sciences research. Together and individually they represent organizations that make investments in basic science, clinical trials and seeing new products brought to market ultimately. Necessarily, intellectual property and licensing play a role in forming the collaborations and managing the work of these organizations. 

The goal of this plenary session is to explain the work of these organizations, their overall objectives and the role that licensing plays. And given that they are all non-profit entities, the panel will explore the implications of licensing involving commercial actors to achieve charitable outcomes.

Moderator:
Chris Rivera, President, WBBA

Panelists:
Erik Iverson, Executive Vice President of Business Development and External Affairs, Infectious Disease Research Institute
Maja Larson, General Counsel, Allen Institute for Brain Science
Richard Wilder, Associate General Counsel, Bill & Melinda Gates Foundation

2:00 – 3:00 EST
Secondary Patent Market - Trends and Practices 

Recent large-scale and high-profile patent transactions have brought the marketplace into sharper focus for businesses, government, and the general public, making it apparent that the IP marketplace, along with its trends and practices, is an increasingly-important aspect of business. This distinguished panel of top dealmakers will share diverse perspectives on patent acquisitions and sales.They'll discuss the state of the secondary market and trends, share best practices, and aim to demystify the patent bubble.

Moderator:
Matt Penarczyk, Associate General Counsel, Microsoft

Panelists:
Michele Baumgartner-Bonanno, Director of IP Strategy, IBM
John Goldstone, Director, Technology Licensing, Weyerhaeuser
Jeremy Salesin, Vice President, Acquisitions, Intellectual Ventures

Thursday, MAY 16
12:30 – 1:30 EST

Hello Kitty as a Global Licensing & Marketing Phenomenon
Sanrio is Japan's leading company in global licensing with products available in over 109 countries. Sanrio's success has been drawing a lot of attention, so much so that it was featured in a special documentary aired in May of 2012 by Japanese public broadcaster NHK. A key figure involved in this success is Ray Hatoyama, who took the company's Hello Kitty brand worldwide, and he will speak about his experiences. His talk will cover themes such as Sanrio's focus on globalizing its business in recent years, the localization of its operations worldwide, and the strong growth in global licensing.

Speaker:
Ray Hatoyama, Vice Chairman, Sanrio

On-Demand Recordings

West Coast Software Giants Focus on IP

Life Sciences: A Guide to Turning a Strategic Partnership into an Acquisition

Getting To Know the Federal and National Laboratories

Start-Ups Using IP to Break New Ground in Mobile Advertising, Marketing and Content Consumption

Deflated in Canada - A Cautionary Tale of the Recent Viagra Ruling

East Meets West - Finding Common Ground for Successful IP Collaborations in China

ePayments: Mobile Payments Demystified!

De-Franchise My License Please!

IP Protection for Start-Ups: Is It Worth It?

Innovation California Style: How are West Coast Companies Getting from Bench to Product?

Tiptoe Through the Jackpots: An Insiders’ Look at the IP in the Gaming Industry

New World of Risk: SaaS Solution, OS, Joint Dev and Risk Management

Innovation Happens When Collaboration Agreements Work

You Thought Halo Was Big: Wait 'Til You See What the IP Has “In Store” – The Xbox Halo Case Study

 

Seminar Information
Seminar Date:
May 15, 2013
Seminar Information
Date Presented:
May 16, 2013 12:30 PM Eastern
Length:
1 hour
Solving the World's Imminent Problems with Innovative Science
The Bill & Melinda Gates Foundation, the Allen Institute for Brain Science, and the Infectious Disease Research Institute are all Seattle-based non-profit organizations that fund, manage and engage in life sciences research. Together and individually they represent organizations that make investments in basic science, clinical trials and seeing new products brought to market ultimately. Necessarily, intellectual property and licensing play a role in forming the collaborations and managing the work of these organizations.
Speaker Information
Erik Iverson   [ view bio ]
Maja Larson   [ view bio ]
Chris E. Rivera   [ view bio ]
Richard Wilder   [ view bio ]
West Coast Software Giants Focus on IP
  • What's top of mind from an IP perspective for each company?
  • What types of deals does the team get involved in?
  • What are the typical IP-related hurdles to clear, and where are the biggest challenges and opportunities moving into the future?

Speaker Information
Rich Foehr   [ view bio ]
Dana Rao   [ view bio ]
Matthew Sarboraria   [ view bio ]
Tiptoe through the Jackpots: An Insiders' Look at the IP in the Gaming Industry
Wager gaming has evolved to a very interesting place in its history. In the last four years, in most of the world, the industry's revenues have remained relatively flat. The primary opportunity for growth has been the expansion of wager-gaming into the internet - particularly in America - which is currently unlawful. This raises at least a couple of very interesting questions.
Speaker Information
Mark Hettinger   [ view bio ]
Kevin Spivak   [ view bio ]
Rob Ziems   [ view bio ]
Life Sciences: A Guide to Turning a Strategic Partnership into an Acquisition
  • Commercializing your platform via strategic partnerships, while retaining enough proprietary to interest a would-be acquirer
  • How to identify appropriate strategic partners
  • When and how to call it quits on an unworkable strategic partnership
  • What terms in a strategic partnership agreement cause the most trouble when a strategic partnership is unwound
  • What do venture investors look for in strategic partnership deals
  • Negotiating terms that pave the way for a successful transition from strategic partnership to acquisition

Speaker Information
Eric Dobmeier   [ view bio ]
Sonya Erickson   [ view bio ]
Beth Etscheid   [ view bio ]
Kenneth Galbraith   [ view bio ]
Jonathan Mow   [ view bio ]
IP Protection for Start-Ups: Is it Worth it?
While comprehensive international patent protection sounds attractive, it can be severely cost-prohibitive. This panel will discuss a pragmatic approach to intellectual property protection for small companies, with a particular focus on technology transfer from research organizations.
Speaker Information
Andrea Belz   [ view bio ]
Rob Berman   [ view bio ]
Dan Broderick   [ view bio ]
Keith Rosema   [ view bio ]
Innovation Happens When Collaboration Agreements Work
Speaker Information
Jeanine Hayes   [ view bio ]
Deborah Lickness   [ view bio ]
Rodger McKinley   [ view bio ]
Robert Pascal   [ view bio ]
Innovation California Style: How are West Coast Companies Getting from Bench to Product?
What is the recipe to nurture novel, innovative ideas to bear fruit in a commercial product? Representatives from the academic, venture capital and founder community address the role each can play in the early stages of taking intellectual property from an academic setting to a startup. The panel will address those initial issues a new innovator company faces in licensing in intellectual property assets and how best to leverage those assets in early stage development deals.
Speaker Information
Hemmie Chang   [ view bio ]
Robert Dunkle   [ view bio ]
Neena Kadaba   [ view bio ]
Alex Suh   [ view bio ]
You Thought Halo was Big: Wait 'Til You See What the IP Has
Speaker Information
Christine Finch   [ view bio ]
Hello Kitty as a Global Licensing & Marketing Phenomenon
Sanrio is Japan's leading company in global licensing with products available in over 109 countries. Sanrio's success has been drawing a lot of attention, so much so that it was featured in a special documentary aired in May of 2012 by Japanese public broadcaster NHK. A key figure involved in this success is Ray Hatoyama, who took the company's Hello Kitty brand worldwide, and he will speak about his experiences. His talk will cover themes such as Sanrio's focus on globalizing its business in recent years, the localization of its operations worldwide, and the strong growth in global licensing.
Speaker Information
Reyhito Hatoyama   [ view bio ]
Start-Ups Using IP to Break New Ground in Mobile Advertising, Marketing, and Content Consumption
Speaker Information
Ivan Braiker   [ view bio ]
Ed Bruno   [ view bio ]
IP Perspectives from a Northwest Angel Investor
Former Microsoft executive turned angel investor in clean tech Brian Arbogast will discuss IP relevance and challenges in the startup world. Brian, an angel investor and advisor, has a background in software strategy, development, and clean tech, and is on the boards of several local startups focused on innovative sustainability. He will discuss trends in impact investing, including business practices for sustainability.
Speaker Information
Brian Arbogast   [ view bio ]
Getting to Know the Federal and National Laboratories
 The panel will discuss everything you ever wanted to know about the federal laboratories, but were afraid to ask. What is a federal lab? What goes on at a federal lab? What is the difference between a "national" and "federal" laboratory?
At a time when our economic future increasingly relies on scientific and engineering expertise, the federal and national laboratories provide critically important know-how and highly specialized facilities. The national and federal laboratories offer productive science, technology and engineering laboratories that provide knowledge and technology for the nation’s benefit.
There are over 300 federal laboratories and centers that provide cutting edge research and solutions. Going beyond their national missions, the laboratories work hand in hand with states, industry and universities to collaboratively solve local problems and pursue new research initiatives. The labs remain a largely untapped resource. Given their many contributions, it is to our advantage to partner and benefit from their knowledge and expertise.

Speaker Information
Daniel Broderick   [ view bio ]
Cheryl Cejka   [ view bio ]
Robin Johnston   [ view bio ]
Ida Shum   [ view bio ]
Mobile Payments Demystified!
Speaker Information
Scott Forbes   [ view bio ]
Jerry Gnuschke   [ view bio ]
Rene Pelegero   [ view bio ]
De-Franchise my License Please!
 Franchising and licensing are closely related concepts. Learn how to blend franchising and trademark and retail licensing. How T-Mobile, Starbucks and other innovative licensors have used franchising or licensing, and have avoided franchise laws or complied with franchise laws.

Speaker Information
Gary Duvall   [ view bio ]
Amy McCune   [ view bio ]
Ed Miller   [ view bio ]
Secondary Patent Market – Trends and Practices
 Recent large-scale and high-profile patent transactions have brought the marketplace into sharper focus for businesses, government, and the general public, making it apparent that the IP marketplace, along with its trends and practices, is an increasingly-important aspect of business. This distinguished panel of top dealmakers will share diverse perspectives on patent acquisitions and sales.  They'll discuss the state of the secondary market and trends, share best practices, and aim to demystify the patent bubble.

Speaker Information
Michelle Baumgartner   [ view bio ]
John Goldstone   [ view bio ]
Matt Penarczyk   [ view bio ]
Jeremy R. Salesin   [ view bio ]
Deflated in Canada – A Cautionary Tale of the Recent Viagra Ruling
 In November of 2012, the Canadian Supreme Court unanimously decided to strike down Pfizer's patent on Viagra due to insufficient disclosure. The court found that Pfizer did not sufficiently disclose the exact compound that was effective in treating erectile disfunction, sildenafil, among a list of 260 quintillion chemical compounds named in the patent; the court also found that Pfizer knew that sildenafil was the effective compound at the time it filed the application but chose not to disclose it expressly (essentially gaming the patent system by playing “hide and seek” with the identification of the one effective compound, by hiding it among other ineffective ones). Is this just a quirky Canadian ruling? Or will lack of clear disclosure become an important issue in other pharma patents or in other jurisdictions? This court decision threw open the Canadian market for generic erectile disfunction drugs and forced Pfizer Canada to drop the Canadian price of Viagra immediately to bring it in line with generic versions. A related development was a class action lawsuit filed in December of 2012 in the Supreme Court of British Columbia on behalf of all purchasers of Viagra in British Columbia up to November, 2012, alleging that Pfizer unlawfully abused the patent system to obtain exclusive monopoly rights in Canada to sell Viagra and seeking to recover the overcharge that class members paid for Viagra up to the end of November, 2012. Could this happen in other jurisdictions? Panelists, which include Canadian, U.S. and European patent attorneys, will review the Canadian case and examine impacts in other jurisdictions, weaving a cautionary tale for those who draft and perform due diligence on pharmaceutical claims.

Speaker Information
Sean Alexander   [ view bio ]
Mae Joanne Rosok   [ view bio ]
Hilton W. C. Sue   [ view bio ]
David H. Takagawa   [ view bio ]
East Meets West – Finding Common Ground for Successful IP Collaborations in China
 Attracted by enormous market potential and relatively inexpensive labor, American companies flocked to China over the past 15 years despite deep concerns over what may become of their IP. Foreign players have begun to navigate the channels for obtaining and enforcing IP through what was once an untested PRC framework. It's now becoming clear that cooperation and rather than opposition is the touchstone for successful operations in China. This session explores where and how to find the common ground to build a foundation for success. The session will highlight the commonalities between U.S. and Chinese IP systems from the procurement and enforcement side, describe the IP challenges and successes of at least two high tech companies doing business in China and provide a perspective of how to turn adversaries into advocates with regard to IP.

Speaker Information
Ted Gizewski   [ view bio ]
Susan Pan   [ view bio ]
Shengping Ying   [ view bio ]
Individual topic purchase: Selected
Products
Streaming
LES Member Price:$295.00